Orthofix Medical (OFIX) Accumulated Depreciation & Amortization (2010 - 2025)

Orthofix Medical (OFIX) has 16 years of Accumulated Depreciation & Amortization data on file, last reported at $77.3 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 28.74% year-over-year to $77.3 million; the trailing twelve-month figure through Dec 2025 stood at $77.3 million (up 28.74% YoY), and the FY2025 full-year result was $77.3 million, up 28.74% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $77.3 million, up from $60.1 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $77.3 million in Q4 2025 and bottomed at $29.0 million in Q4 2022.
• A 5-year average of $49.8 million and a median of $53.1 million in 2023 frame the typical range for Accumulated Depreciation & Amortization.
• Across the five-year window, Accumulated Depreciation & Amortization retreated 3.1% in 2021 and soared 82.86% in 2023, its largest moves.
• Tracing OFIX's Accumulated Depreciation & Amortization over 5 years: stood at $29.6 million in 2021, then declined by 1.96% to $29.0 million in 2022, then soared by 82.86% to $53.1 million in 2023, then gained by 13.19% to $60.1 million in 2024, then gained by 28.74% to $77.3 million in 2025.
• According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $77.3 million, $60.1 million, and $53.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison